- Home
- MYNZ vs DSS Comparison
MYNZ vs DSS Comparison
Compare MYNZ & DSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MYNZ
- DSS
- Stock Information
- Founded
- MYNZ 2021
- DSS 1984
- Country
- MYNZ Germany
- DSS United States
- Employees
- MYNZ N/A
- DSS N/A
- Industry
- MYNZ Biotechnology: Pharmaceutical Preparations
- DSS Containers/Packaging
- Sector
- MYNZ Health Care
- DSS Consumer Discretionary
- Exchange
- MYNZ Nasdaq
- DSS Nasdaq
- Market Cap
- MYNZ 7.6M
- DSS 8.8M
- IPO Year
- MYNZ 2021
- DSS N/A
- Fundamental
- Price
- MYNZ $2.04
- DSS $1.15
- Analyst Decision
- MYNZ Buy
- DSS
- Analyst Count
- MYNZ 2
- DSS 0
- Target Price
- MYNZ $14.00
- DSS N/A
- AVG Volume (30 Days)
- MYNZ 185.7K
- DSS 52.0K
- Earning Date
- MYNZ 08-05-2025
- DSS 08-12-2025
- Dividend Yield
- MYNZ N/A
- DSS N/A
- EPS Growth
- MYNZ N/A
- DSS N/A
- EPS
- MYNZ N/A
- DSS N/A
- Revenue
- MYNZ $893,991.00
- DSS $20,180,000.00
- Revenue This Year
- MYNZ $26.06
- DSS N/A
- Revenue Next Year
- MYNZ $4.97
- DSS N/A
- P/E Ratio
- MYNZ N/A
- DSS N/A
- Revenue Growth
- MYNZ N/A
- DSS 12.88
- 52 Week Low
- MYNZ $1.34
- DSS $0.72
- 52 Week High
- MYNZ $19.00
- DSS $1.54
- Technical
- Relative Strength Index (RSI)
- MYNZ 57.11
- DSS 70.75
- Support Level
- MYNZ $1.89
- DSS $0.85
- Resistance Level
- MYNZ $2.25
- DSS $1.39
- Average True Range (ATR)
- MYNZ 0.22
- DSS 0.09
- MACD
- MYNZ 0.05
- DSS 0.03
- Stochastic Oscillator
- MYNZ 76.14
- DSS 57.14
About MYNZ Mainz Biomed N.V.
Mainz Biomed NV develops market-ready molecular genetic diagnostic solutions for life-threatening conditions. The company's flagship product is ColoAlert, is an accurate, non-invasive and easy-to-use, early-detection diagnostic test for colorectal cancer based on real-time Polymerase Chain Reaction-based (PCR) multiplex detection of molecular-genetic biomarkers in stool samples. The company operates in one operating segment, genetic diagnostic testing.
About DSS DSS Inc.
DSS Inc is operating a business focused on Five operating segments Product Packaging, Biotechnology, Commercial Lending, Securities and Investment Management, and Direct Marketing. Currently operates five distinct business lines operate around the globe with primary operations in North America and Asia. Product packaging manufactures, and sells sophisticated custom folding cartons, mailers, photo sleeves and complex three-dimensional direct mail solutions. Biotechnology division targets unmet, urgent medical needs and expands the borders of medical and pharmaceutical science. Commercial Lending through represents its banking and financing business line. Alternative Trading develops and/or acquires assets and investments in the securities trading and/or fund management arena.